Fundraising FoxMercury Fund — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
GlycosBio conducts research and development using engineered lipid technologies to improve the bioavailability and therapeutic performance of natural bioactive molecules, including approaches targeting the intestinal, pulmonary, and skin microbiota.
BiotechDeep TechHealthtechHouston, US
Richard C. Jr. Cilento(Executive Officer, Director)
BoardFrank Foster(Director)inJoseph Walowski(Director)Victoria Niklas(Director)
Board seatDan Watkins· per SEC Form D · $1M raise · filed Apr 2023
Co-investorsGideon Hixon FundGreen Park & Golf VenturesTexas HALO FundFuture Ventures
Otto (TeleVet) builds technology for veterinary clinics and animal hospitals to help them connect with pet owners and manage their practice.
AI & Machine LearningHealthtechSaaSAustin, US
Price Fallin(Co-founder)inSteven Carter(Co-founder)inAllie Esch(Director)
Board seatHeath ButlerBlair Garrou· per SEC Form D
Co-investorsUrban Capital NetworkDundee Venture Capital
Trava delivers red team services that simulate real-world adversary behavior to test an organization's detection and response capabilities across the full attack lifecycle.
CybersecurityDefense TechEnterprise SoftwareSaaSIndianapolis, US
Jim Goldman(Executive Officer, Director)Rob Beeler(Executive Officer, Director)Matt Bressler(Director)
BoardScott Dorsey(Director)in
Board seatAziz Gilani· per SEC Form D
Co-investorsElevate VenturesHigh AlphaRiverside Acceleration Capital
Blumira offers a cloud-based security operations platform that combines SIEM, endpoint detection, identity threat detection, and cloud monitoring to detect and respond to threats, surfacing actionable cases with guided response playbooks and compliance reporting.
Cloud ComputingCybersecuritySaaS
Co-investorsArray Ventures Management LlcRPS VenturesTen ElevenHyde Park AngelsM25
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.